PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.




PMID- 29595922
OWN - NLM
STAT- MEDLINE
DCOM- 20180330
LR  - 20180330
IS  - 1533-4406 (Electronic)
IS  - 0028-4793 (Linking)
VI  - 378
IP  - 13
DP  - 2018 Mar 29
TI  - Osimertinib in EGFR Mutation-Positive Advanced NSCLC.
PG  - 1261
LID - 10.1056/NEJMc1801669 [doi]
FAU - Ward, Matthew C
AU  - Ward MC
FAU - Prabhu, Roshan S
AU  - Prabhu RS
FAU - Burri, Stuart H
AU  - Burri SH
LA  - eng
PT  - Letter
PT  - Comment
DEP - 20180329
PL  - United States
TA  - N Engl J Med
JT  - The New England journal of medicine
JID - 0255562
RN  - 0 (Piperazines)
RN  - 3C06JJ0Z2O (osimertinib)
RN  - EC 2.7.10.1 (EGFR protein, human)
RN  - EC 2.7.10.1 (Receptor, Epidermal Growth Factor)
SB  - AIM
SB  - IM
CON - N Engl J Med. 2018 Jan 11;378(2):113-125. PMID: 29151359
CIN - N Engl J Med. 2018 Mar 29;378(13):1261-1263. PMID: 29590540
MH  - *Carcinoma, Non-Small-Cell Lung
MH  - Humans
MH  - Lung Neoplasms
MH  - Mutation
MH  - *Piperazines
MH  - Receptor, Epidermal Growth Factor/genetics
EDAT- 2018/03/30 06:00
MHDA- 2018/03/31 06:00
CRDT- 2018/03/30 06:00
PHST- 2018/03/30 06:00 [entrez]
PHST- 2018/03/30 06:00 [pubmed]
PHST- 2018/03/31 06:00 [medline]
PST - epublish
SO  - N Engl J Med. 2018 Mar 29;378(13):1261.